Arcellx (ACLX) Depreciation & Amortization (CF) (2021 - 2025)

Arcellx (ACLX) recorded quarterly Depreciation & Amortization (CF) of $1.6 million in Q4 2025, down 10.96% quarter-over-quarter from $1.8 million in Q3 2025, and down 8.27% on a YoY basis from $1.8 million in Q4 2024.

Arcellx (ACLX) Depreciation & Amortization (CF) (2021 - 2025) Analysis & Trends

Arcellx's Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2025.

  • In Q4 2025, Depreciation & Amortization (CF) fell 8.27% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $6.7 million (up 28.72% YoY), while the FY2025 annual figure was $6.7 million, up 28.72% from the prior year.
  • Depreciation & Amortization (CF) was $1.6 million for Q4 2025 at Arcellx, down from $1.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.8 million in Q3 2025 to a low of $207000.0 in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $813400.0 across 5 years, with a median of $443000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) jumped 198.43% in 2024, then retreated 8.27% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $331000.0 in 2021, then gained by 25.68% to $416000.0 in 2022, then soared by 73.56% to $722000.0 in 2023, then surged by 147.78% to $1.8 million in 2024, then slipped by 8.27% to $1.6 million in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $1.6 million (Q4 2025), $1.8 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 1,395.22
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -1,330.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 55.90 Mn
9 Abivax 94.37 Bn 94.37 Bn - 429,663.65
10 Arcellx 6.48 Bn 6.48 Bn - 1.64 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.64 Mn
Dec 31, 2025 1.64 Mn
Sep 30, 2025 1.84 Mn
Sep 30, 2025 1.84 Mn
Jun 30, 2025 1.62 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 1.58 Mn
Mar 31, 2025 1.58 Mn
Dec 31, 2024 1.79 Mn
Dec 31, 2024 1.79 Mn
Sep 30, 2024 1.33 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.24 Mn
Jun 30, 2024 1.24 Mn
Mar 31, 2024 826,000.00
Mar 31, 2024 826,000.00
Dec 31, 2023 722,000.00
Dec 31, 2023 722,000.00
Sep 30, 2023 447,000.00
Sep 30, 2023 447,000.00